911 Improved lifelines needed for all lines: real-world treatment patterns and attrition rates in US patients with non-driver mutation metastatic non-small cell lung cancer by Chen Hu, Charlene Wong, Iftekhar Kalsekar, Qing Huang, Aisha Hasan, Josephine Feliciano, Adam Schoenfeld, Ravi Rajaram, Urmila Chandran, U Hariharan, Tianyi Wang

296 A comprehensive clinical and genomic characterization of long-term responders receiving immune checkpoint blockade for metastatic non-small cell lung cancer by Patrick Forde, Julie Brahmer, Vincent Lam, Christine Hann, Melinda Hsu, Josephine Feliciano, Kristen Marrone, Joseph Murray, Paola Ghanem, David Ettinger, Benjamin Levy

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes by Lei Zheng, Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Cheng Ting Lin, Peter B Illei, Sonye K Danoff, Karthik Suresh, Christine Hann, Aanika Balaji, Melinda Hsu, Josephine Feliciano, Kristen Marrone, Valerie Lee

Get full text

Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-s... by Melissa A.L. Vyfhuis, MD PhD, Neha Bhooshan, MD PhD, Whitney M. Burrows, MD, Michelle Turner, NP, Mohan Suntharalingam, MD MBA, James Donahue, MD, Elizabeth M. Nichols, MD, Josephine Feliciano, MD, Søren M. Bentzen, PhD DMSc, Shahed Badiyan, MD, Shamus R. Carr, MD, Joseph Friedberg, MD, Charles B. Simone, II, MD, Martin J. Edelman, MD, Steven J. Feigenberg, MD, Pranshu Mohindra, MD

Get full text